Unraveling the mechanism of Lianqiaobaidu powder in viral myocarditis: Complementary actions within cardiac cell types

Na Tang; Shuqiao Xing; Ting Zhou; Wen-Hui Qi; Bingyan Wang; Chengwen Li; Wei Cao; Zhi-Jing Zhao; Yingfeng Lei; Xiao-Qiang Li

doi:10.1016/j.jpha.2026.101595

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2026 > Accepted Manu

Na Tang, Shuqiao Xing, Ting Zhou, Wen-Hui Qi, Bingyan Wang, Chengwen Li, Wei Cao, Zhi-Jing Zhao, Yingfeng Lei, Xiao-Qiang Li. Unraveling the mechanism of Lianqiaobaidu powder in viral myocarditis: Complementary actions within cardiac cell types[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2026.101595

Citation:

Na Tang, Shuqiao Xing, Ting Zhou, Wen-Hui Qi, Bingyan Wang, Chengwen Li, Wei Cao, Zhi-Jing Zhao, Yingfeng Lei, Xiao-Qiang Li. Unraveling the mechanism of Lianqiaobaidu powder in viral myocarditis: Complementary actions within cardiac cell types[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2026.101595

Citation:

Na Tang, Shuqiao Xing, Ting Zhou, Wen-Hui Qi, Bingyan Wang, Chengwen Li, Wei Cao, Zhi-Jing Zhao, Yingfeng Lei, Xiao-Qiang Li. Unraveling the mechanism of Lianqiaobaidu powder in viral myocarditis: Complementary actions within cardiac cell types[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2026.101595

PDF( 35414 KB)

Unraveling the mechanism of Lianqiaobaidu powder in viral myocarditis: Complementary actions within cardiac cell types

doi: 10.1016/j.jpha.2026.101595

Na Tang^a,b,c,d,
Shuqiao Xing^a,b,c,e,
Ting Zhou^a,b,c,d,
Wen-Hui Qi^a,b,c,d,
Bingyan Wang^b,e,
Chengwen Li^a,b,c,d,
Wei Cao^b,e,
Zhi-Jing Zhao^d,
Yingfeng Lei^{f
,
,},
Xiao-Qiang Li^{a,b,c,d
,
,}

a. Department of Chinese Materia Medica and Natural Medicines, School of Pharmacy, Air Force Medical University, Xi'an, 710032, China;
b. Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Air Force Medical University, Xi'an, 710032, China;
c. Shaanxi Key Laboratory of "Qin Medicine" Research and Development, Air Force Medical University, Xi'an, 710032, China;
d. Innovation Research Institution, Xijing Hospital, Air Force Medical University, Xi'an, 710032, China;
e. Department of Pharmacy, School of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, 712100, China;
f. Department of Microbiology, College of Basic Medicine, Air Force Medical University, Xi’an, 710032, China

Funds:

CVB3 (Nancy strain, ATCC No.: VR-30) was kindly provided by Prof. Zhen Luo of Jinan University, Guangzhou, China. CVB3-specific anti-VP1 antibody was kindly donated by Prof. Zhaohua Zhong from Harbin Medical University, Harbin, China.

Received Date: Nov. 08, 2025
Accepted Date: Mar. 01, 2026
Rev Recd Date: Feb. 27, 2026
Available Online: Mar. 12, 2026

Abstract

FullText(HTML)

References(5)

References

[1]	M. Imazio, Inflammatory cardiomyopathy: an update for clinicians, Trends. Cardiovasc. Med. 36 (2026) 1 - 11.
[2]	Y. Cao, X. Xu, P. Zhang, Advances in the Traditional Chinese Medicine-Based Management of Viral Myocarditis, Cell Biochem. Biophys. 73 (2015) 237 - 243.
[3]	K. Yu, L. Zhou, Y. Wang, et al., Mechanisms and therapeutic strategies of viral myocarditis targeting autophagy, Front. Pharmacol. 13 (2022) 843103.
[4]	K.R. Pressley, Y. Naseem, S. Nalawade, et al., The distinct functions of MIF in inflammatory cardiomyopathy, Front. Immunol. 16 (2025) 1544484.
[5]	R. Karki, B.R. Sharma, S. Tuladhar, et al., Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes, Cell 184 (2021) 149 - 168.e117.